Related Experiment Video
Updated: Jun 22, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Notch signaling pathway in ovarian cancer
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA. srose2@wisc.edu
Abstract:
The literature is replete with reports of the paradoxical role of Notch signaling in human cancer. Notch appears to act as both an oncogene and a tumor suppressor gene depending on the cellular context. This review focuses on the nascent knowledge of Notch signaling in ovarian cancer. Despite advances in chemotherapy and radical surgery, ovarian cancer remains the most deadly gynecologic malignancy. Therapeutic improvements are necessary to enhance outcomes of patients with ovarian cancer. I will review the evidence for Notch activation in ovarian cancer and potential strategies for Notch inactivation as targeted treatment of ovarian cancer.
Insights
Notch signaling plays a complex role in cancer, acting as both an oncogene and tumor suppressor. This review explores Notch
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Ovarian cancer remains a leading cause of cancer-related deaths in women globally.
- Current treatments like chemotherapy and surgery have limitations, necessitating novel therapeutic strategies.
- Notch signaling is implicated in various cancers, exhibiting context-dependent oncogenic or tumor-suppressive functions.
Purpose of the Study:
- To review the current understanding of Notch signaling in ovarian cancer.
- To investigate the evidence for Notch pathway activation in ovarian cancer.
- To explore potential therapeutic strategies targeting Notch inactivation for ovarian cancer treatment.
Main Methods:
- Literature review of existing studies on Notch signaling and ovarian cancer.
- Analysis of evidence for Notch pathway involvement in ovarian cancer pathogenesis.
- Identification of potential therapeutic targets within the Notch signaling pathway.
Main Results:
- The review highlights the dual role of Notch signaling in cancer, influencing tumor development and progression.
- Evidence suggests Notch pathway activation in a significant proportion of ovarian cancer cases.
- Specific Notch pathway components are identified as potential targets for therapeutic intervention.
Conclusions:
- Notch signaling is a critical player in ovarian cancer, with its activation correlating with disease progression.
- Targeting Notch inactivation presents a promising avenue for developing novel ovarian cancer therapies.
- Further research is warranted to elucidate the precise mechanisms and optimize therapeutic strategies.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways

